Skip to main content
Equibles
BBIO $66.75 +0.21%
BBIO logo
BBIO · BridgeBio Pharma, Inc.
Track BBIO — free

Use BBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$66.75 +0.14 (+0.21%)
Russell 1000 member Rebalance outlook locked
Market Cap
$13.37B
Shares
195.49M
All earnings calls

Earnings call · FY2021 Q2

BridgeBio Pharma, Inc. (BBIO) Q2 2021 Earnings Call

Concluded Aug 13, 2021
Aug 13, 2021 0 turns
Period
FY2021 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $54.02M
Diluted EPS -$0.66
Net income -$102.07M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 13, 2021 10-Q report Filed Aug 5, 2021

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License And Service$53.04M
Product$987,000
Full-screen source Call document

BBIO transcript alerts

BridgeBio Pharma, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →